INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of D-Wave Quantum Inc.

Pomerantz LLP is investigating potential securities-fraud claims involving D-Wave Quantum after Q2 2026 revenue of $3.08 million missed analyst expectations of $4.03 million-$4.08 million and was slightly below the prior-year $3.10 million. QBTS fell $1.99, or 9.28%, to $19.41 following the August 6 results, then declined another $1.84, or 9.51%, to $17.51 after CFO John Markovich announced his retirement effective September 2. The legal investigation, earnings miss and abrupt CFO departure create elevated governance and litigation risk for the company.

Analysis

The legal-advertising release is not itself a fundamental catalyst; the investable issue is whether the recent operating miss and finance-leadership transition force a reset in the market’s assumed commercialization curve. For QBTS, whose valuation is likely driven far more by future enterprise adoption than near-term earnings, even modest reductions in expected bookings or revenue growth can produce disproportionate multiple compression. The immediate risk is therefore not litigation damages but a weaker next-quarter outlook, delayed contract conversion, or disclosure that elevates perceived reporting/control risk.

Read-through to IONQ and RGTI should be limited unless subsequent data point to a broad pullback in quantum customer spending: D-Wave’s annealing-focused offering and customer base are not clean proxies for gate-model platforms. Conversely, a sector-wide selloff could create relative-value opportunity if peers show materially stronger backlog conversion, cash runway, and customer concentration metrics. Over the next 1-3 months, monitor executive succession, revised commercial KPIs, cash burn, and insider activity; a credible CFO replacement and reaffirmed forward metrics could trigger a sharp short-covering rally given the stock’s high-beta retail ownership profile.

Consensus may overemphasize the legal headline after the equity decline. Plaintiff-law-firm investigations frequently follow sharp price moves and do not independently establish misconduct. The bearish thesis is falsified if management provides auditable evidence of improving bookings-to-revenue conversion and extends liquidity without punitive dilution; absent that evidence, the 6-18 month structural risk is repeated equity issuance funding a commercialization timeline that remains longer than the valuation implies.

Key Decisions for Investors

• Do not initiate a directional position solely on the litigation announcement; treat it as a governance-risk flag, not a confirmed liability. Reassess after CFO succession details and the next earnings release.
• For existing QBTS longs, reduce exposure or hedge over the next 1-3 months using a put spread around the next earnings date; the downside case is a guidance/KPI reset, while a defined-risk structure preserves upside if the transition is orderly.
• Conditional relative-value trade: long IONQ versus short QBTS only if IONQ demonstrates superior bookings conversion, liquidity runway, and customer diversification in its next reporting cycle. Exit if QBTS names a credible CFO and provides forward commercial metrics that narrow those gaps.
• Set alerts for a secondary offering, going-concern/liquidity commentary, auditor or internal-control disclosures, and any revision to revenue or bookings guidance; any of these would validate a renewed QBTS short thesis, whereas their absence alone does not.